Last reviewed · How we verify

NCT04382508: ImmunoCOVID

Coronavirus Infection in Primary or Secondary Immunosuppressed Children and Adults.

Status unknown Last updated 20 May 2020
What this trial tests

trial testing Questionnaire in Immune Suppression in 1,500 participants. Status unknown.

Timeline
22 March 2020
Primary endpoint
21 March 2021
21 March 2021

Quick facts

Lead sponsorUniversity Hospital Southampton NHS Foundation Trust
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment1,500
Start date22 March 2020
Primary completion21 March 2021
Estimated completion21 March 2021
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital Southampton NHS Foundation Trust

Who can join

Eligibility, any sex, with Immune Suppression or Immune Deficiency. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A weekly questionnaire is sent to patients and parents of patients who are vulnerable for infections. Possible symptoms of COVID19 are asked for and use of healthcare services and testing for COVID19. Weekly reports are being send to the national institutions to update advice given to this group.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. COVID-19 symptom surveillance in immunocompromised children and young people in the UK: a prospective observational cohort study.
    Shaunak M, Patel R, Driessens C, Mills L, et al · · 2021 · cited 10× · PMID 33737439 · DOI 10.1136/bmjopen-2020-044899

Verify or expand the search:

Other trials of Questionnaire

Trials testing the same drug.

Other recruiting trials for Immune Suppression

Currently open trials in the same condition.

Other University Hospital Southampton NHS Foundation Trust trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04382508.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing